Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
memantine (namenda) (1 trial)
Down Syndrome (Phase 2)
Intellectual Disability (Phase 2)
Syndrome (Phase 2)
Trials (1 total)
Trial APIs (1 total)